- Home
- DOYU vs SOPH Comparison
DOYU vs SOPH Comparison
Compare DOYU & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- SOPH
- Stock Information
- Founded
- DOYU 2014
- SOPH 2011
- Country
- DOYU China
- SOPH Switzerland
- Employees
- DOYU N/A
- SOPH N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOYU Technology
- SOPH Health Care
- Exchange
- DOYU Nasdaq
- SOPH Nasdaq
- Market Cap
- DOYU 195.9M
- SOPH 219.8M
- IPO Year
- DOYU 2019
- SOPH 2021
- Fundamental
- Price
- DOYU $7.31
- SOPH $3.62
- Analyst Decision
- DOYU Hold
- SOPH Buy
- Analyst Count
- DOYU 1
- SOPH 1
- Target Price
- DOYU $7.00
- SOPH $7.00
- AVG Volume (30 Days)
- DOYU 49.3K
- SOPH 168.0K
- Earning Date
- DOYU 05-20-2025
- SOPH 08-05-2025
- Dividend Yield
- DOYU 271.09%
- SOPH N/A
- EPS Growth
- DOYU N/A
- SOPH N/A
- EPS
- DOYU N/A
- SOPH N/A
- Revenue
- DOYU $575,786,186.00
- SOPH $67,173,000.00
- Revenue This Year
- DOYU N/A
- SOPH $16.07
- Revenue Next Year
- DOYU N/A
- SOPH $22.94
- P/E Ratio
- DOYU N/A
- SOPH N/A
- Revenue Growth
- DOYU N/A
- SOPH 4.66
- 52 Week Low
- DOYU $5.68
- SOPH $2.58
- 52 Week High
- DOYU $20.17
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- DOYU 61.50
- SOPH 70.98
- Support Level
- DOYU $7.05
- SOPH $2.81
- Resistance Level
- DOYU $7.44
- SOPH $3.40
- Average True Range (ATR)
- DOYU 0.29
- SOPH 0.30
- MACD
- DOYU 0.09
- SOPH 0.07
- Stochastic Oscillator
- DOYU 72.18
- SOPH 98.31
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.